semaglutide in early pregnancy GLP-1 receptor agonists should not be used in pregnancy - When to stopsemaglutidebeforepregnancy has not been studied in pregnant people

I got pregnant while takingsemaglutide Semaglutide in Early Pregnancy: What the Research Says

The use of semaglutide (marketed as Ozempic and Wegovy) during pregnancy, particularly in early pregnancy, is a topic of significant concern and ongoing research. While semaglutide has shown effectiveness for managing type 2 diabetes and chronic weight management, its safety profile for expectant mothers and developing fetuses is not yet fully established. Medical experts and regulatory bodies generally advise against its use during pregnancy due to potential risks and a lack of comprehensive human data.

Understanding Semaglutide and Pregnancy Risks

Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists (GLP-1 RAs). These medications work by mimicking the action of the GLP-1 hormone, which helps regulate blood sugar and appetite. However, concerns arise regarding their impact on fetal development.

* Limited Human Data: A significant challenge in assessing the semaglutide in early pregnancy safety is the limited availability of studies conducted specifically on pregnant individuals. Many health organizations, including the manufacturer of semaglutide, advise that it should not be taken during pregnancy. This recommendation stems from the fact that the drug has not been studied in pregnant people, and the effects on fetal development are not well understood.

* Animal Studies: Preclinical animal studies have indicated potential risks associated with GLP-1 RA use during gestation作者：RF DRUMMOND·被引用次数：59—You should stop using [Semaglutide] 2 months before you plan to become pregnant.” 27.. These studies have suggested a higher risk of early pregnancy loss and reduced fetal weight, potentially due to maternal weight loss, which is generally not recommended during pregnancy2024年10月1日—Weight loss is not recommended during pregnancy, and the product label for Wegovy® recommends that it not be used in pregnancy. It is .... Some research also points to a risk of embryofetal mortality, structural abnormalities, and alterations to growth with semaglutide use.

* Pregnancy Categories and Warnings: In the United States, Ozempic (semaglutide) is classified as a Category C drug by the FDA, meaning that animal reproduction studies have shown an adverse effect on the fetus and there have been no adequate and well-controlled studies in pregnant women. Some sources list semaglutide as a pregnancy category D medication, which indicates that there is positive evidence of human fetal risk2025年5月19日—Semaglutide Pregnancy Warnings​​ Additionallyweight loss offers no benefit to a pregnant patientand may cause fetal harm. Comments:. The product label for Wegovy® explicitly recommends that it not be used in pregnancy.

* Impact on Weight Management: A primary indication for some semaglutide formulations is weight lossDoes Semaglutide Affect Fertility or Pregnancy?. However, weight loss is not recommended during pregnancy as it can deprive the fetus of essential nutrients. Therefore, weight loss offers no benefit to a pregnant patient and may actually cause fetal harm.

Current Research and Expert Opinions

Despite the general cautionary stance, some early research has emerged, yielding mixed results:

* First Trimester Exposure: One early study suggested that using GLP-1 agonists during the first trimester didn't harm fetal development.2023年10月1日—They stayed on semaglutide for the first 3 to 4 weeks of their pregnancyand gave birth to a child without reported birth defects. In animal ... Another study focusing on pregnancy outcomes following first trimester exposure to semaglutide added to a growing body of literature and indicated there is no increased risk of major congenital anomalies. However, these findings are often from limited semaglutide exposed pregnancies and require further validation.

* Mixed Results: More comprehensive reviews of semaglutide exposed pregnancies have shown mixed results. While some studies reported no significant adverse outcomes, others have identified a higher risk of preterm birth, large for gestational age (LGA) infants, and neonatal complications like hypoglycemia and jaundice. The Wegovy Pregnancy Registry aims to collect more data to improve our understanding of safety.

* Recommendations for Discontinuation: Due to the paucity of data and potential risks, the manufacturer advises stopping semaglutide treatment at least 2 months before conceptionIs Semaglutide Safe During Pregnancy?. Other experts recommend that women planning a pregnancy should temporarily stop, or delay starting, GLP-1 meds.作者：L Kolding·2025·被引用次数：13—Semaglutide‐exposed pregnancies had a higher risk ofpreterm birth, large for gestational age (LGA), neonatal hypoglycemia and jaundice compared ... The general consensus among healthcare professionals is that semaglutide is not recommended during pregnancy and should be discontinued prior to conceiving.

The Phenomenon of "Ozempic Babies"

The rise in the use of semaglutide for weight management has led to a phenomenon sometimes referred to as "Ozempic babies.作者：K Dao·2024·被引用次数：76—10 Due to the paucity of data concerning semaglutide and human pregnancy outcomes, the manufacturer advises stopping this treatment 2 months before conception." This occurs when a pregnancy is conceived while a woman is taking semaglutide, often before she is aware of the pregnancy. It's possible for a pregnancy to be exposed to GLP-1 RA medication for weeks or even months before the pregnancy is detected. While some anecdotal reports and early studies suggest that brief early exposure (particularly before you knew you were pregnant) does not necessarily lead to adverse outcomes, it's not clear yet whether GLP-1 medications are safe for use in early pregnancyOzempic Babies | Blog.

Key Takeaways for Women of Reproductive Age

* Contraception and Planning: Women of reproductive age considering or taking semaglutide should discuss contraception and pregnancy planning with their healthcare provider. It is advised to stop using [Semaglutide] 2 months before you plan to become pregnant.

* Wegovy Pregnancy Registry: If you become pregnant while taking Wegovy, you may be eligible to enroll in the Wegovy Pregnancy Registry. This registry helps healthcare providers and researchers gather vital information on pregnancy outcomes.

* Consult Your Doctor: If you are pregnant or planning to become pregnant and are currently using semaglutide, it is crucial to consult your doctor immediately.Glucagon-like peptide-1 receptor agonist use in pregnancy They can provide personalized advice based on your individual health status and the latest scientific evidenceOzempic Babies? What Research Says About Semaglutide .... While semaglutide is generally considered to be safe for its intended uses, it is not recommended for pregnant women. The safest course of action is to adhere to medical guidance and prioritize the health of both mother and child.

In conclusion, while there is ongoing research, the available evidence suggests that semaglutide poses potential risks during pregnancy. Therefore, it is currently recommended against its use in pregnancy, and women planning to conceive should discuss discontinuing the medication with their healthcare provider well in advance. The GLP-1 receptor agonists should not be used in pregnancy due to insufficient safety data'Ozempic Babies': How GLP-1 Agonists Affect Fertility.